Status:
COMPLETED
Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma
Lead Sponsor:
University of Florida
Conditions:
Musculoskeletal Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Musculoskeletal trauma is one of the leading causes of disability in the United States and its negative quality of life impact extends beyond that of physical recovery. More than 50% of victims of mus...
Detailed Description
Rationale Over 50% of victims of musculoskeletal trauma suffer prolonged depressive and anxious symptomology following their initial injury. This is an independent risk factor for prolonged mental an...
Eligibility Criteria
Inclusion
- patients 18 and older under the care of the UF Orthopedic Trauma Division admitted to UF Health for trauma resulting in one or more extremity or pelvic fractures requiring surgery will be screened.
Exclusion
- patients with Traumatic Brain Injury or a past medical history of bipolar or other mental health conditions on current medical management will be excluded
- patients unlikely to follow up (live in at a distance from Gainesville, incarcerated etc.) will also be excluded.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2025
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04850222
Start Date
September 1 2021
End Date
February 17 2025
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32608